STOCK TITAN

Vanguard holds 4,088,168 shares of QuidelOrtho (NASDAQ: QDEL)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

QuidelOrtho Corp ownership filing: Vanguard Portfolio Management reports beneficial ownership of 4,088,168 shares of common stock, representing 6% of the class as of 03/31/2026. The filer reports 56,400 shares of sole voting power and sole dispositive power over 4,088,168 shares. The filing is signed on 04/29/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard holds a 6% stake in QuidelOrtho, primarily in dispositive control.

Vanguard Portfolio Management reports beneficial ownership of 4,088,168 shares, with sole dispositive power over the same amount and limited sole voting power of 56,400 shares. This pattern is typical when asset managers hold securities across multiple pooled funds or client accounts.

Ownership is reported under a Schedule 13G structure and reflects aggregator reporting across Vanguard entities; subsequent filings could show changes in percent ownership if positions shift.

Filing follows Schedule 13G aggregation rules and includes affiliate disclosure.

The filing cites SEC Release No. 34-39538 and clarifies that dispositive power is exercised by Vanguard Portfolio Management LLC and certain affiliates, including Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. The statement explains aggregated holdings across funds and managed accounts.

The document discloses that no single other person holds more than 5% and provides the issuer CUSIP 219798105 for precise identification.

Shares beneficially owned 4,088,168 shares Beneficial ownership reported as of 03/31/2026
Percent of class 6% Percent of common stock class as reported
Sole voting power 56,400 shares Sole power to vote or direct the vote
Sole dispositive power 4,088,168 shares Sole power to dispose or direct disposition
CUSIP 219798105 Issuer identifier for QuidelOrtho common stock
Filing signature date 04/29/2026 Signed by Ashley Grim, Head of Global Fund Administration
Schedule 13G regulatory
"Name of form: SCHEDULE 13G reporting beneficial ownership"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownership financial
"Amount beneficially owned: 4088168"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 4088168"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
CUSIP financial
"CUSIP Number(s): 219798105"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How many QuidelOrtho (QDEL) shares does Vanguard report owning?

Vanguard reports beneficial ownership of 4,088,168 shares of QuidelOrtho common stock, representing 6% of the class as of 03/31/2026. The filing aggregates holdings across Vanguard Portfolio Management and specified affiliates.

What voting and dispositive powers does Vanguard report for QDEL?

Vanguard reports 56,400 shares of sole voting power and sole dispositive power over 4,088,168 shares. The filing indicates voting and dispositive powers are exercised by Vanguard Portfolio Management LLC and listed affiliates.

What document did Vanguard file to report this stake in QDEL?

The ownership is reported on a Schedule 13G for QuidelOrtho common stock, including the issuer CUSIP 219798105. The filing cites SEC Release No. 34-39538 for aggregation of affiliate holdings.

Does the filing identify any other person with over 5% of QDEL?

No. The filing states that no one other person's interest in the reported securities is over 5%. Vanguard notes holdings include investment company shares and managed accounts.

What are the relevant dates shown in Vanguard’s QDEL filing?

The reported ownership is tied to the date 03/31/2026, and the filing is signed on 04/29/2026 by Ashley Grim, Head of Global Fund Administration for Vanguard Portfolio Management.





219798105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Portfolio Management LLC and the following affiliates of Vanguard Portfolio Management LLC or business divisions of such affiliates: Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Portfolio Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Portfolio Management LLC, or business divisions of such subsidiaries whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


SCHEDULE 13G



Vanguard Portfolio Management
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:04/29/2026